WuXi Biologics (Cayman) Inc (WXIBF)
1.63
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
WuXi Biologics Price: 1.63 for May 3, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 03, 2024 | 1.63 | 1.63 | 1.63 | 1.63 | 0.000 |
May 02, 2024 | 1.63 | 1.63 | 1.63 | 1.63 | 0.000 |
May 01, 2024 | 1.63 | 1.63 | 1.63 | 1.63 | 380.00 |
Apr 30, 2024 | 1.68 | 1.68 | 1.68 | 1.68 | 0.000 |
Apr 29, 2024 | 1.68 | 1.68 | 1.68 | 1.68 | 0.000 |
Apr 26, 2024 | 1.68 | 1.68 | 1.68 | 1.68 | 8890.00 |
Apr 25, 2024 | 1.645 | 1.645 | 1.645 | 1.645 | 0.000 |
Apr 24, 2024 | 1.645 | 1.645 | 1.645 | 1.645 | 65500.00 |
Apr 23, 2024 | 1.695 | 1.695 | 1.695 | 1.695 | 0.000 |
Apr 22, 2024 | 1.695 | 1.695 | 1.695 | 1.695 | 0.000 |
Apr 19, 2024 | 1.695 | 1.695 | 1.695 | 1.695 | 0.000 |
Apr 18, 2024 | 1.695 | 1.695 | 1.695 | 1.695 | 9400.00 |
Apr 17, 2024 | 1.70 | 1.70 | 1.70 | 1.70 | 0.000 |
Apr 16, 2024 | 1.70 | 1.70 | 1.70 | 1.70 | 3300.00 |
Apr 15, 2024 | 1.702 | 1.702 | 1.702 | 1.702 | 100.00 |
Apr 12, 2024 | 1.81 | 1.81 | 1.81 | 1.81 | 0.000 |
Apr 11, 2024 | 1.81 | 1.81 | 1.81 | 1.81 | 0.000 |
Apr 10, 2024 | 1.81 | 1.81 | 1.81 | 1.81 | 175.00 |
Apr 09, 2024 | 1.67 | 1.67 | 1.67 | 1.67 | 0.000 |
Apr 08, 2024 | 1.67 | 1.67 | 1.67 | 1.67 | 0.000 |
Apr 05, 2024 | 1.67 | 1.67 | 1.67 | 1.67 | 0.000 |
Apr 04, 2024 | 1.67 | 1.67 | 1.67 | 1.67 | 0.000 |
Apr 03, 2024 | 1.67 | 1.67 | 1.67 | 1.67 | 0.000 |
Apr 02, 2024 | 1.67 | 1.67 | 1.67 | 1.67 | 859.00 |
Apr 01, 2024 | 1.87 | 1.87 | 1.85 | 1.85 | 8500.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.63
Minimum
May 01 2024
34.25
Maximum
Nov 16 2020
8.148
Average
6.68
Median
Mar 16 2022
Price Benchmarks
Wuxi AppTec Co Ltd | 4.77 |
Zai Lab Ltd | 16.25 |
I-MAB | 1.76 |
Gracell Biotechnologies Inc (DELISTED) | 10.25 |
Price Related Metrics
PE Ratio | 14.96 |
PS Ratio | 2.956 |
Price to Book Value | 1.192 |
Price to Free Cash Flow | 115.31 |
Earnings Yield | 6.68% |
Market Cap | 6.785B |
Operating PE Ratio | 11.29 |
Normalized PE Ratio | 14.29 |